The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

Abstract Introduction An Alzheimer's disease (AD) biomarker adjusted for age‐related brain changes should improve specificity for AD‐related pathological burden. Methods We calculated a brain‐age‐adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Annie M. Racine, Michael Brickhouse, David A. Wolk, Bradford C. Dickerson, Alzheimer's Disease Neuroimaging Initiative
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley 2018-01-01
Schriftenreihe:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Schlagworte:
AD index
AD signature
Alzheimer's disease
Cortical thickness
Mild cognitive impairment
Online Zugang:https://doi.org/10.1016/j.dadm.2018.02.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge